8-KLeadership ChangesExhibits & Filings

AMGEN INC 8-K Report, Executive Changes (Oct 22, 2010)

Filed October 22, 2010For Securities:AMGN

Summary

This 8-K filing from Amgen Inc. (AMGN) on October 21, 2010, primarily reports on the transition of George J. Morrow, Executive Vice President, following his announced retirement. The company has entered into a one-year consulting services agreement with Mr. Morrow, effective February 1, 2011, extending his engagement beyond his retirement date. The agreement aims to leverage Mr. Morrow's expertise in critical areas such as R&D product pipeline commercialization and product launches. This arrangement provides Amgen with continued access to valuable institutional knowledge and strategic insight during a period of significant product development and market introduction. Investors can view this as a measure to ensure continuity and smooth transitions in key operational areas.

Key Highlights

  • 1Amgen Inc. has entered into a one-year consulting agreement with Executive Vice President George J. Morrow, effective February 1, 2011.
  • 2Mr. Morrow is retiring from his executive role effective January 31, 2011.
  • 3The consulting agreement aims to utilize Mr. Morrow's expertise in commercialization of the R&D product pipeline and product launches.
  • 4Compensation for the consulting services includes a quarterly fee of $100,000 for up to 80 hours of service per quarter, with additional hourly rates for extra hours.
  • 5The agreement allows for an optional extension for a second year.
  • 6Amgen will reimburse Mr. Morrow for reasonable travel-related expenses incurred during his consulting services, excluding travel to the Thousand Oaks facility.
  • 7The consulting agreement includes provisions for conflict of interest and allows for termination by either party with 30 days' notice.

Frequently Asked Questions

Amgen is entering into a consulting agreement with George J. Morrow to retain his valuable expertise and experience in crucial areas like R&D product pipeline commercialization and product launches. This ensures continuity and smooth transitions during key strategic periods.

Mr. Morrow will be compensated with $100,000 quarterly for up to 80 hours of service per quarter. Additional hours beyond 80 (up to a maximum of 160 per quarter) will be compensated at $1,200 per hour. Amgen will also reimburse reasonable travel expenses.

The consulting agreement is for an initial term of one year, commencing February 1, 2011. There is an option to extend the agreement for a second year by mutual agreement.

Yes, Mr. Morrow agrees not to accept any employment or consulting arrangement that would present a conflict of interest during the term of the consulting agreement. Acceptance of such an engagement could be considered a material breach and lead to termination of the agreement.